Predicting glycemic responses to food using limited data could allow for personalized nutrition planning for individuals with ...

Key points A 28-year-old man with cocaine and alcohol use disorders presented to the emergency department with a 2-month history of worsening shortness of breath, orthopnea, and fatigue. His medical ...

Bobbi Conner talks with MUSC's Dr. Remberto Paulo about the symptoms, diagnosis and management of type 1 diabetes in children ...

Managing diabetes is more than just staying away from sweets, it requires proper information and guidance to live healthy.

Researchers at Pennington Biomedical Research Center have revealed critical insights into how impaired mitochondrial dynamics ...

This week on the Inside EMS podcast, hosts Chris Cebollero and Kelly Grayson tackle a metabolic monster that every EMS ...

Q1 2025 Earnings Call Transcript April 30, 2025 Tandem Diabetes Care, Inc. misses on earnings expectations. Reported EPS is $ ...

Using the latest data and perspectives, an international expert panel releases updated recommendations for optimal insulin ...

Baltimore Ravens' Mark Andrews teamed up with the Cardinals' Trey McBride to put on the 2nd annual Rockin' Protein Tight End ...

Recent advances in diabetes technology have transformed the clinical management of type 1 diabetes in children and adolescents. The integration of ...

Tandem Diabetes Care achieves record Q1 2025 sales with 22% growth, launches Control-IQ+ for type 2 diabetes, doubling its market potential.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.